BRIEF-Luye Pharma Group Says Registration Application Of Rivastigmine Transdermal Patch Accepted

In this article:

Sept 17 (Reuters) - Luye Pharma Group Ltd:

* REGISTRATION APPLICATION OF RIVASTIGMINE TRANSDERMAL PATCH ACCEPTED BY CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION Source text for Eikon: Further company coverage:

Advertisement